Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.09

-1.7%

3:09 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (4471)	8/14/2001 12:56:11 PM
From: Jibacoa	Read Replies (1) of 52153

<<One sleeper in this area is the use of statins for dementia/Alzheimers. The beneficiary here if this pans out is ADRX >> Excuse my ignorance.<g> Does ADRX has other statin drug besides Avicor ? I thought Avicor was only a sustained release version of MRK's Mevacor. In which way will ADRX benefit more if statins are approved for Alzheimers ? Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next